Infecção pelo SARS-Cov-2 e Tromboembolismo Pulmonar – Comportamento Pró - Trombótico da COVID-19
Hellen Dutra Passos, Mariana Carvalho Alves, Leonardo Baumworcel, João Paulo Cerqueira Vieira, Juliane Dantas Seabra-Garcez, Antônio Carlos Sobral Sousa
Abstract
Introduction The COVID-19 caused by new coronavirus, named by the World Health Organization as Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), has spread all over the world with astonishing speed. In Brazil, the spread risk (R0) of COVID-19 has been 3.0, which explains its rapid dissemination all over the states. Individuals with cardiovascular diseases, systemic arterial hypertension, diabetes mellitus, chronic obstructive pulmonary disease, and immunosuppressed patients are at higher risk for adverse outcomes. […] SARS-Cov-2 Infection and Pulmonary Thromboembolism – [...]
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiabetes mellitusCoronavirusPulmonary diseaseDiseaseInternal medicineIntensive care medicineVirologyInfectious disease (medical specialty)OutbreakEndocrinologyCOVID-19 Clinical Research StudiesHealthcare RegulationLong-Term Effects of COVID-19